Award recordCONTRACT

EMBECTA CORP

PIID 36E79723D0010· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES· FY2023· $0 net obligations· UEI NHDJR297RV75· NJ

Description

EXERCISE OPTION YEAR 3, EFFECTIVE APRIL 23, 2026, TO APRIL 22, 2027, FOR INSULIN SYRINGES WITH EMBECTA CORP. ECONOMIC PRICE ADJUSTMENT INCLUDED IN OPTION YEAR 3 PRICES.

Base award description: NEW AWARD FOR INSULIN SYRINGES WITH BECTON, DICKINSON AND COMPANY. ORDERING PERIOD IS APRIL 23, 2023 TO APRIL 22, 2024 WITH FOUR ONE-YEAR OPTIONS.

First action · last action
2022-12-29 · 2026-03-02
Transactions
13
First transaction's obligation
$0
Base + all options value (sum of deltas)
$23,217,097
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
11
SDVOSB flag on record
No
NAICS
339112 · SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING

Modification chain · 13 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2022-12-29 · this action $0 · running total $0Modification P00001 · 2023-10-02 · this action $0 · running total $0Modification P00002 · 2023-12-28 · this action $0 · running total $0Modification P00003 · 2023-12-28 · this action $0 · running total $0Modification P00004 · 2024-02-15 · this action $0 · running total $0Modification P00005 · 2024-02-26 · this action $0 · running total $0Modification P00006 · 2024-04-23 · this action $0 · running total $0Modification P00007 · 2024-10-11 · this action $0 · running total $0Modification P00008 · 2025-02-24 · this action $0 · running total $0Modification P00009 · 2025-03-26 · this action $0 · running total $0Modification P00010 · 2025-10-20 · this action $0 · running total $0Modification P00011 · 2026-01-29 · this action $0 · running total $0Modification P00012 · 2026-03-02 · this action $0 · running total $0
  • Base2022-12-29+$0= $0
  • Mod P000012023-10-02+$0= $0
  • Mod P000022023-12-28+$0= $0
  • Mod P000032023-12-28+$0= $0
  • Mod P000042024-02-15+$0= $0
  • Mod P000052024-02-26+$0= $0
  • Mod P000062024-04-23+$0= $0
  • Mod P000072024-10-11+$0= $0
  • Mod P000082025-02-24+$0= $0
  • Mod P000092025-03-26+$0= $0
  • Mod P000102025-10-20+$0= $0
  • Mod P000112026-01-29+$0= $0
  • Mod P000122026-03-02+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2022-12-29+$0$0NEW AWARD FOR INSULIN SYRINGES WITH BECTON, DICKINSON AND COMPANY. ORDERING PERIOD IS APRIL 23, 2023 TO APRIL…
Mod P00001· ADD SUBCONTRACTING PLAN2023-10-02+$0$0MODIFICATION TO INCORPORATE SMALL BUSINESS SUBCONTRACTING PLAN INTO CONTRACT #36E79723D0010. THE SUBCONTRACTIN…
Mod P00002· NOVATION AGREEMENT2023-12-28+$0$0MODIFICATION TO INCORPORATE NOVATION AGREEMENT - NOVATION FROM BECTON, DICKINSON AND COMPANY TO EMBECTA CORP F…
Mod P00003· ADD SUBCONTRACTING PLAN2023-12-28+$0$0INCORPORATION OF EMBECTA CORP 2024 SMALL BUSINESS SUBCONTRACTING PLAN FOR CONTRACT #36E79723D0010 - INSULIN SY…
Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-02-15+$0$0MODIFICATION FOR THE SUPPLEMENTAL CHANGES TO THE CRF PAYMENT SUBMITTAL AND SALES REPORTING REQUIREMENTS.
Mod P00005· EXERCISE AN OPTION2024-02-26+$0$0EXERCISE OPTION YEAR 1, EFFECTIVE APRIL 23, 2024 TO APRIL 22, 2025 FOR INSULIN SYRINGES WITH EMBECTA CORP. ECO…
Mod P00006· OTHER ADMINISTRATIVE ACTION2024-04-23+$0$0FEI NUMBER UPDATE
Mod P00007· ADD SUBCONTRACTING PLAN2024-10-11+$0$0INCORPORATION OF EMBECTA CORP 2025 SMALL BUSINESS SUBCONTRACTING PLAN FOR CONTRACT #36E79723D0010 - INSULIN SY…
Mod P00008· EXERCISE AN OPTION2025-02-24+$0$0EXERCISE OPTION YEAR 2, EFFECTIVE APRIL 23, 2025, TO APRIL 22, 2026, FOR INSULIN SYRINGES WITH EMBECTA CORP. E…
Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-03-26+$0$0DUE TO AN FDA REQUIREMENT, NDC/NHRIC CODES ON MEDICAL DEVICE PACKAGING MUST BE REPLACED WITH NRC CODES. THEREF…
Mod P00010· ADD SUBCONTRACTING PLAN2025-10-20+$0$0INCORPORATION OF EMBECTA CORP 2026 SMALL BUSINESS SUBCONTRACTING PLAN FOR CONTRACT #36E79723D0010 - INSULIN SY…
Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2026-01-29+$0$0MODIFICATION TO DELETE OLD NDCS FROM CONTRACT 36E79723D0010, AS STOCK IS COMPLETELY EXHAUSTED FROM THE DISTRIB…
Mod P00012· EXERCISE AN OPTION2026-03-02+$0$0EXERCISE OPTION YEAR 3, EFFECTIVE APRIL 23, 2026, TO APRIL 22, 2027, FOR INSULIN SYRINGES WITH EMBECTA CORP. E…

Related awards · 7

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NHDJR297RV75)

AwardOffice · PSC / listingNet obligationsFY
36C24124A0008241-NETWORK CONTRACT OFFICE 01 (36C241) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$0FY2024
36E79723D0011NAC PHARMACEUTICALS (36E797) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$0FY2023

Other recipients under 6515 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79721D0033C R BARD INCNAC PHARMACEUTICALS (36E797)$0FY2021
36E79721D0019VETERANS HEALTHCARE SUPPLY SOLUTIONS, INCNAC PHARMACEUTICALS (36E797)$0FY2021
36E79721D0015MARATHON MEDICAL CORPORATIONNAC PHARMACEUTICALS (36E797)$0FY2021
36E79721D0002BECTON, DICKINSON AND CONAC PHARMACEUTICALS (36E797)$0FY2021
36E79720D0074MEDLINE INDUSTRIES, LPNAC PHARMACEUTICALS (36E797)$0FY2020

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79723D0010_3600 · retrieved 2026-09-26.